How to improve clinical trials
Involving more participants can lead to new medical insights
Last year Roche, a Swiss pharmaceutical firm, published a review of the clinical trials on neurological drugs it had held between 2016 and 2021. It found that black people were under-represented in all but one. Surprisingly, that news represents progress, because it shows that trial organisers are becoming more aware of a dangerous bias that sets back the safety and efficacy of medical treatments.
Explore more
This article appeared in the Leaders section of the print edition under the headline “Moving the needle ”
From the January 18th 2025 edition
Discover stories from this section and more in the list of contents
Explore the edition
President Trump’s attacks on the Fed are not over
Jerome Powell wins a reprieve. But expect more showdowns between the White House and the Fed
Brazil’s Supreme Court is on trial
How a superstar judge illuminates an excessive concentration of power
Don’t overlook the many benefits of plastics
If they are a problem, it is because they are badly managed
The lesson of Birmingham’s striking binmen
The moment is ripe to reform Britain’s equal-pay rules
How a dollar crisis would unfold
If investors keep selling American assets, a grim fate awaits the world economy
Zuckerberg on trial: why Meta deserves to win
Social media has plenty of problems. Lack of competition isn’t one of them